In the clinical practice setting, current tools that measure the signs of atopic dermatitis (AD) in clinical trials may not be practical due to their complexity. A simpler approach was evaluated for quickly assessing severity of signs in AD.
Learn more at the Journal of the American Academy of Dermatology.